Department of Health
and Human Services (HHS)
and Human Services (HHS)
May 6, 2020
National Institute of Allergy and Infectious Diseases (NIAID)
The purpose of this Notice is to alert potential applicants of a change to the Key Dates for RFA-AI-20-004, Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed).
The following changes have been made:
Part 1. Overview Information
Key Dates
Currently reads:
Posted Date
February 6, 2020
Open Date (Earliest Submission Date)
May 29, 2020
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
June 29, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
November 2020
Advisory Council Review
January 2021
Earliest Start Date
April 2021
Expiration Date
June 30, 2020
Due Dates for E.O. 12372
Not Applicable
Revised to read:
Posted Date
February 6, 2020
Open Date (Earliest Submission Date)
June 20, 2020
Letter of Intent Due Date(s)
30 days prior to the application due date
Application Due Date(s)
July 20, 2020
All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
AIDS Application Due Date(s)
Not Applicable
Scientific Merit Review
November 2020
Advisory Council Review
January 2021
Earliest Start Date
April 2021
Expiration Date
July 21, 2020
Due Dates for E.O. 12372
Not Applicable
All other aspects of this FOA remain unchanged.
Please direct all inquiries to:
Cheryl Lapham, Ph.D.
National Institute of Allergy and Infectious Diseases (NIAID)
Telephone: 240-498-1366
Email: clapham@niaid.nih.gov